Company Overview of EuroFerm GmbH
EuroFerm GmbH develops and produces materials for microcapsulation of living organisms and cells. The company's platform technology allows to produce recombinant proteins for diagonstic and/or therapeutic purposes. EuroFerm GmbH produces insect-pathogene viruses for biological pest control, as well as recombinant proteins and immobilisation by sodiumcellulosesulfate. The company was formerly known as EuroFerm Gesellschaft für Fermentation und Messtechnik mbH and changed its name to EuroFerm GmbH in September 2004. EuroFerm GmbH was founded in 1994 and is based in Erlangen, Germany.
Founded in 1994
49 9131 97 79 49 0
49 9131 97 79 49 9
Key Executives for EuroFerm GmbH
EuroFerm GmbH does not have any Key Executives recorded.
Similar Private Companies By Industry
|4 Animals AlsterScience GmbH||Europe|
|Acousia Therapeutics GmbH||Europe|
|Across Barriers GmbH||Europe|
|Actinodrug Pharmaceuticals GmbH||Europe|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|The Advertising Council, Inc.||United States|
|NYC2012, Inc.||United States|
|Tax Management Inc||United States|
|John F. Kennedy Center For The Performing Arts||United States|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.
To contact EuroFerm GmbH, please visit --. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.